|
Aug 27
|
Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
|
|
Jun 24
|
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
|
|
Jun 20
|
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
|
|
Feb 7
|
Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher
|
|
Feb 5
|
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
|
|
Jan 11
|
All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy
|
|
Dec 24
|
This Silence Therapeutics Insider Increased Their Holding In The Last Year
|
|
Dec 1
|
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
|